However, large randomized trials that
focused on cardiovascular outcomes have reported that in patients
without vascular disease (and who are roughly similar to participants
in the adenoma trials), aspirin had no substantial effect on ischemic
stroke risk in men ( 23 , 24 ), and may reduce this risk in women ( 23 ).